Among the “significant” peptides, S2–78 (aa 1148–1159) has a diagnostic performance comparable to that of the S1 protein for the detection of COVID-19 and asymptomatic infection, suggesting that S2–78 has the potential to be used in serological prevalence investigations. This evidence concerns the gene PSMD1 and COVID-19.